2021 · FINDING
CITEDSTEP Trials
14.9% avg weight loss vs 2.4% placebo over 68 weeks
⚕ EDUCATIONAL CONTENT · NOT MEDICAL ADVICE · CONSULT A QUALIFIED PHYSICIAN BEFORE ANY USE
WEIGHT LOSSFDA APPROVED★ TOP SEARCHED
Semaglutide.
The King of Weight Loss Peptides
AKA · Ozempic · Wegovy · Rybelsus
WEIGHT LOSSSUBCUTANEOUSORAL
If you've heard of Ozempic, you've heard of semaglutide. Originally for Type 2 diabetes, it became a phenomenon when people started losing 15-20% of their body weight.
~7 days
Half-life
5
Citations
2
Routes
1
Categories
Refrigerate
Storage
100
Popularity
AT A GLANCE.
§ 01 · TL;DRTHE QUICK READ.
If you've heard of Ozempic, you've heard of semaglutide. Originally for Type 2 diabetes, it became a phenomenon when people started losing 15-20% of their body weight.
Mimics GLP-1, a hormone that tells your brain you're full, slows digestion, and regulates blood sugar.
WHAT IT MIGHT HELP WITH.
1
15-20% body weight loss in clinical trials
2
Reduced appetite and 'food noise'
3
Improved blood sugar control
4
Cardiovascular benefits
5
Reduced inflammation markers
HOW IT WORKS.
§ 02 · MECHANISMMimics GLP-1, a hormone that tells your brain you're full, slows digestion, and regulates blood sugar.
GLP-1 receptor agonist binding to hypothalamus, pancreas, and gut receptors. 94% homology to native GLP-1 provides ~7 day half-life.
WHO IT'S FOR
- ✓BMI ≥30 (obesity)
- ✓BMI ≥27 with weight-related conditions
- ✓Type 2 diabetics
- ✓Those who've failed diet/exercise
WHO SHOULD AVOID
- ✕Family history of medullary thyroid cancer
- ✕History of pancreatitis
- ✕Pregnant/planning pregnancy
THE RESEARCH.
§ 03 · 5 STUDIES2023 · FINDING
CITEDSELECT Trial
20% reduction in cardiovascular events
2024 · FINDING
CITEDFLOW Trial (Kidney Outcomes)
24% reduction in kidney disease progression in patients with type 2 diabetes and CKD
2024 · FINDING
CITEDSTEP-HFpEF Trial
Significant improvement in heart failure symptoms and exercise capacity in HFpEF patients
2024 · FINDING
CITEDCagriSema Combination
Semaglutide + Cagrilintide combination achieved up to 22.7% weight loss in Phase 2
DOSING PROTOCOL.
§ 04 · DOSINGTYPICAL RANGE
Research reported dose
Start 0.25mg weekly, titrate to 2.4mg over 16-20 weeks
FREQUENCY
Most-cited schedule
Once weekly (injection) or daily (oral)
ROUTES
Delivery methods
SUBCUTANEOUS · ORAL
HALF-LIFE
Steady state drives frequency
~7 days
STORAGE
Protect from light, refrigerate
Refrigerate at 36-46°F
⚠ NOTE
These are reported protocols from research literature and practitioner accounts, not prescriptions. No FDA-approved human dose exists for research compounds. Anyone using Semaglutide should work with a qualified physician and source from a supplier providing third-party COAs.
FORMS AVAILABLE
- · Subcutaneous injection (Ozempic, Wegovy)
- · Oral tablet (Rybelsus)
⚠ RESEARCH INFORMATION ONLY · NOT MEDICAL ADVICE
SIDE EFFECTS & RISKS.
§ 06 · SAFETY·
Nausea
Very common (40-50%) · mild
Improves with slow titration
·
Vomiting
Common (25%) · mild
·
Diarrhea
Common (20%) · mild
·
Constipation
Common (15%) · mild
!
Pancreatitis
Rare · serious
Seek care if severe abdominal pain
WHERE TO SOURCE
§ 07 · SUPPLIERPEAK LAB
PEPTIDES
PEPTIDES
SUPPLIER OF RECORD · 12 BATCHES PASSED
We tried nine suppliers across 2025 and kept picking PEAK LAB for Semaglutide: 99.4% HPLC purity, COA on every batch, cold chain intact. Shop through our link and we earn a small commission — affiliate relationship is disclosed.
COMMON QUESTIONS.
§ 08 · FAQHow long until research studies observed weight loss?
According to clinical trials, most participants began observing weight changes within 4-8 weeks, with significant results typically documented by week 12-16. Individual responses varied considerably.
What happens if a dose is missed in research protocols?
Clinical guidelines suggest administering the missed dose within 5 days. If more than 5 days have passed, protocols typically recommend skipping and resuming the regular schedule.
Why do studies recommend slow dose titration?
Research demonstrates that gradual dose increases over 16-20 weeks significantly reduce GI side effects compared to rapid titration, improving adherence and tolerability.
Can weight return after discontinuation?
Studies indicate that without lifestyle modifications, weight regain is common after discontinuation. Long-term data suggests ongoing use may be necessary to maintain results.
What about 'Ozempic face'?
This term describes facial volume loss observed with significant weight loss. It's not specific to semaglutide - any substantial weight reduction can cause similar effects.
MORE ON SEMAGLUTIDE.
§ 10 · FIELD NOTES◆ Education · ★ FEATURE
Beginner's Guide to GLP-1 Peptides: Semaglutide vs Tirzepatide
Everything beginners need to know about GLP-1 peptides — how they work, key differences between semaglutide and tirzepatide, and what researchers report.
11 min·READ →
◆ Comparisons · ★ FEATURE
Semaglutide vs Tirzepatide: Complete Comparison (2026)
In-depth comparison of semaglutide and tirzepatide — mechanisms, weight loss data, side effects, costs, and which GLP-1 peptide is right for different research goals.
14 min·READ →
◆ Education
Are Peptides Safe? What the Research Says
An honest look at peptide safety — FDA-approved vs research peptides, risks, and how to minimize them.
9 min·READ →
◆ THE PEPGAINS DISPATCH
GET THE NEXT UPDATE FIRST.
New research on Semaglutide + a weekly dispatch on everything else moving in the peptide world. One email. Unsubscribe in a click.